A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice

Journal of Immunology

Volumn 180, Issue 1, 2008, Pages 58-63

  Jin, Liang ^a   Zhu, Aihua ^b   Wang, Yu ^a   Chen, Qingmei ^a   Xiong, Qiyan ^a   Li, Jianping ^a   Sun, Yunxiao ^a   Li, Taiming ^a   Cao, Rongyue ^a   Wu, Jie ^a   Liu, Jingjing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b JIANGSU NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; CYTOKINE; HEAT SHOCK PROTEIN 65 PLUS PEPTIDE P277 FUSION PROTEIN; UNCLASSIFIED DRUG; HEAT SHOCK PROTEIN; PEPTIDE 277, HEAT SHOCK PROTEIN 60; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN; VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; IMMUNIZATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; TANDEM REPEAT; TH1 CELL; TH2 CELL; ANIMAL; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; CELL PROLIFERATION; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; HEAT-SHOCK PROTEINS; MICE; MICE, INBRED NOD; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; REPETITIVE SEQUENCES, AMINO ACID; TH1 CELLS; TH2 CELLS; VACCINES;

EID: 40449111136     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.1.58     Document Type: Article

References (33)

1. Daneman, D. 2006. Type 1 diabetes. Lancet 367: 847-858.
2. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140: 52-58.
3. + T-cells from diabetic versus prediabetic NOD.NOD-Thy-la donors. Diabetes 42: 44-55.
4. Mosmann, T. R., and R. L. Coffiman. 1989. TH1 and TH2 cells, different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
5. Banchereau, J., and M. E. Rybak. 1994. Interleukin 4. In The Cytokines Handbook, 2nd Ed. A. Thompson, ed. Academic Press, London, pp. 99-126.
6. Moore, K. V., A. O'Garra, M. R. de Waal, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11: 165-190.
7. Katz, J. D., C. Benoist, and D. Mathis. 1995. T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188.
8. + Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95: 2979-2985.
9. Tisch, R., B. Wang, and D. V. Serreze. 1999. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J. Immunol. 163: 1178-1187.
10. Quintana, F. J., P. Carmi, and I. R. Cohen. 2002. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J. Immunol. 169: 6030-6035.
11. Roep, B. O. 1996. Perspective in diabetes: T-cell responses to autoantigens in IDDM, the search for the Holy Grail. Diabetes 45: 1147-1156.
12. Elias, D., D. Markovits, T. Reshef, Z. R. Van der, and I. R. Cohen. 1990. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 87: 1576-1580.
13. Elias, D., T. Reshef, O. S. Birk, Z. R. Van der, M. D. Walker, and I. R. Cohen. 1991. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88: 3088-3091.
14. Maryam, F. H., M. O. Frantz, and P. A. Morel. 2000. Prevention of diabetes in the NOD mouse by a Th1 clone specific for a hsp60 peptide. J. Autoimmun. 14: 133-142.
15. Jana, B., D. Elias, and I. R. Cohen. 1997. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies. J. Autoimmun. 10: 323-329.
16. Francisco, J. Q., A. Rotem, P. Carmi, and I. R. Cohen. 2000. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity. J. Immunol. 165: 6148-6155.
17. Oscherwitz, J., M. E .Zeigler, C. J. Loh., T. E. Gribbin, and K. B. Cease. 1997. The enhanced immunogenicity of a recombinant immunogen containing a tandemly repeated HIV-1 T helper epitope is an intrinsic immunological property unrelated to epitope dose. Vaccine Res. 6: 15-25.
18. Richard, L. M., P. Martineau, M. Hofnung, and C. Leclerc. 1993. Induction of T-cell responses by chimeric bacterial proteins expressing several copies of a viral T-cell epitope. Eur. J. Immunol. 23: 2998-3002.
19. Jin, L., Y. Wang, Q. Y. Xiong, Q. M. Chen, J. P. Li, A. H. Zhu, R. Y. Cao, J. Wu, and J. J. Liu. 2007. Long-lasting specific antibodies against P277 induced by mucosal administration of P277 repeat sequences carried by Hsp65 in the absence of adjuvants. Vaccine 25: 2043-2050.
20. Birk, O. S., D. Elias, A. S. Weiss, A. Rosen, R. van-der Zee, M. D. Walker, and I. R. Cohen. 1996. NOD mouse diabetes: the ubiquitous mouse hsp60 is a β-cell target antigen of autoimmune T cells. J. Autoimmun. 9: 159-166.
21. Elias, D., A. Meilin, V. Ablamunits, O. S. Birk, P. Carmi, S. Konen-Waisman, and I. R. Cohen. 1997. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and down-regulates autoimmunity to various β-cell antigens. Diabetes 46: 758-764.
22. Elias, D., and I. R. Cohen. 1994. Peptide therapy for diabetes in NOD mice. Lancet 343: 704-706.
23. Elias, D., and I. R. Cohen. 1995. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes 44: 1132-1138.
24. Mamula, M. J., and C. A. Janeway. 1993. Do B cells drive the diversification of immune responses? Immunol. Today 14: 151-153.
25. Kurt-Jones, E. A., D. Liano, K. A. HayGlass, B. Benacerraf, M. S. Sy, and A. K. Abbas. 1988. The role of antigen-presenting B cells in T cell priming in vivo: studies of B cell-deficient mice. J. Immunol. 140: 3773-3778.
26. Michal, C. S., N. Gabriel, P. F. Meirav, M. Felix, C. Pnina, Z. Z. Alexandra, L. Ofer, and I. R. Cohen. 2005. Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J. Immunol. 175: 3594-3602.
27. Jide, T., Z. Dan, H. Lorraine, L. Yuxin, O. Angelica, and L. K. Daniel. 2001. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice 1. J. Immunol. 167: 1081-1089.
28. Emiko, M., M. Atsushi, I. P. Frederic, and K. B. Atul. 2000. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int. Immunol. 12: 597-605.
29. Faria, A. M. C., and H. L. Weiner. 1999. Oral tolerance: mechanisms and therapeutic applications. Adv. Immunol. 73: 153-264.
30. Maron, R., G. Sukhova, A. M. Faria, E. Hoffmann, F. Mach, P. Libby, and H. L. Weiner. 2002. Mucosal administration of hsp65 decreases atherosclerosis and inflammation in Aortic Arch of low-density lipoprotein receptor-deficient mice. Circulation 106: 1708-1715.
31. Weimer, H. L., C. A. Lemere, and R. Maron. 2000. Nasal administration of amyloid-β peptide decreases cerebral amyloid burden in mouse model of Alzheimer's disease. Ann. Neurol. 48: 567-579.
32. Cohen, I. R. 1992. The cognitive principle challenges clonal selection. Immunol. Today 13: 441-444.
33. Cohen, I. R. 1992. The cognitive paradigm and the immunological homunculus. Immunol. Today 13: 490-494.